BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38478773)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Cannabis and Cannabinoids in Patients With Cancer.
    Sawtelle L; Holle LM
    Ann Pharmacother; 2021 Jul; 55(7):870-890. PubMed ID: 33070617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
    Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
    JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care.
    Abrams DI
    Integr Cancer Ther; 2022; 21():15347354221081772. PubMed ID: 35225051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis and schizophrenia.
    McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials.
    AminiLari M; Wang L; Neumark S; Adli T; Couban RJ; Giangregorio A; Carney CE; Busse JW
    Sleep; 2022 Feb; 45(2):. PubMed ID: 34546363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis in cancer care.
    Abrams DI; Guzman M
    Clin Pharmacol Ther; 2015 Jun; 97(6):575-86. PubMed ID: 25777363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews.
    Montero-Oleas N; Arevalo-Rodriguez I; Nuñez-González S; Viteri-García A; Simancas-Racines D
    BMC Complement Med Ther; 2020 Jan; 20(1):12. PubMed ID: 32020875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.
    Sexton M; Garcia JM; Jatoi A; Clark CS; Wallace MS
    J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):86-98. PubMed ID: 34850897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive and Negative Effects of Cannabis and Cannabinoids on Health.
    Cohen K; Weizman A; Weinstein A
    Clin Pharmacol Ther; 2019 May; 105(5):1139-1147. PubMed ID: 30703255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis for Symptom Management in Older Adults.
    Levy C; Galenbeck E; Magid K
    Med Clin North Am; 2020 May; 104(3):471-489. PubMed ID: 32312410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.
    Abrams DI
    Eur J Intern Med; 2018 Mar; 49():7-11. PubMed ID: 29325791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cannabis and cannabinoids in palliative care].
    Rasche T; Emmert D; Radbruch L; Conrad R; Mücke M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):830-835. PubMed ID: 31161228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of medical cannabinoids in older subjects: a systematic review.
    van den Elsen GA; Ahmed AI; Lammers M; Kramers C; Verkes RJ; van der Marck MA; Rikkert MG
    Ageing Res Rev; 2014 Mar; 14():56-64. PubMed ID: 24509411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
    [No Abstract]   [Full Text] [Related]  

  • 37. Introduction to special issue: Therapeutic and abuse-related effects of cannabis and cannabinoids.
    Acheson A; Fantegrossi WE
    Exp Clin Psychopharmacol; 2019 Aug; 27(4):299-300. PubMed ID: 31355665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
    Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
    Mücke M; Carter C; Cuhls H; Prüß M; Radbruch L; Häuser W
    Schmerz; 2016 Feb; 30(1):25-36. PubMed ID: 26809975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.